A detailed history of Kingdon Capital Management, L.L.C. transactions in Insmed Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 200,000 shares of INSM stock, worth $12.9 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
200,000
Previous 405,000 50.62%
Holding current value
$12.9 Million
Previous $12.6 Million 56.76%
% of portfolio
0.66%
Previous 1.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $1.29 Million - $1.5 Million
50,000 Added 12.35%
455,000 $12.3 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $9.49 Million - $12.9 Million
405,000 New
405,000 $12.6 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.74B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.